Zhongquan Sun
221 West Yan'an Road
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 08, 2025
Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trial.
Journal: Signal transduction and targeted therapy
Published: June 10, 2025
Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China.
Journal: Cancer medicine
Published: January 08, 2024
Proxalutamide in metastatic castration-resistant prostate cancer: Primary analysis of a multicenter, randomized, open-label, phase 2 trial.
Journal: International journal of cancer
Published: November 09, 2022
Long-term prognosis and prognostic factors of brachytherapy and propensity score matched comparisons of the outcomes between brachytherapy and radical prostatectomy: a retrospective cohort study.
Journal: Translational andrology and urology
Published: October 31, 2022
Camrelizumab plus famitinib for advanced or metastatic urothelial carcinoma after platinum-based therapy: data from a multicohort phase 2 study.
Journal: Journal for immunotherapy of cancer
Published: April 07, 2022
Activity and safety of SHR3680, a novel antiandrogen, in patients with metastatic castration-resistant prostate cancer: a phase I/II trial.
Journal: BMC medicine
Published: November 15, 2021
Camrelizumab plus Famitinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: Data from an Open-label, Multicenter Phase II Basket Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 11, 2021
A multicenter observational study of the real-world use of docetaxel for metastatic castration-resistant prostate cancer in China.
Journal: Asia-Pacific journal of clinical oncology
Published: October 23, 2018
Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
Journal: International journal of oncology
Published: August 09, 2016
Systematic review and meta-analysis of randomised trials of perioperative outcomes comparing robot-assisted versus open radical cystectomy.
Journal: BMC urology
Published: July 14, 2016
Last Updated: 09/26/2026